U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with D

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
182863 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID ENDOSINUSIAL IMPLANT 1.35 mg Correction
182865 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID INTRAVITREAL IMPLANT 116.00 mg Correction
182867 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID INTRAVITREAL INJECTION 116.00 mg Correction
182869 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID SUBCUTANEOUS INJECTION, SOLUTION 533.00 mg Correction
182871 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 63000 ACID SUBCUTANEOUS INJECTION, SUSPENSION, EXTENDED RELEASE 37mg Correction
182873 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 63000 ACID INTRAMUSCULAR INJECTION 60.70 mg Correction
182875 Q4 2022 DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 63000 ACID SUBCUTANEOUS IMPLANT 16mg Correction
182877 Q4 2022 DL-LACTIDE AND GLYCOLIDE (75:25) COPOLYMER 20000 ACID INTRAMUSCULAR INJECTION 145mg Correction
182949 Q4 2022 D&C YELLOW NO. 10 ORAL SUSPENSION/ DROPS NA Deletion
182950 Q4 2022 DISTEAROYLPHOSPHATIDYLCHOLINE, DL- INTRAVENOUS INJECTION 0.68 %w/v Deletion
183039 Q3 2022 D&C RED NO. 33 ORAL CAPSULE 0.39 mg MDE Replacement
183040 Q4 2022 D&C RED NO. 33 ORAL CAPSULE 1mg MDE Replacement
183041 Q3 2022 DIMETHYL SULFOXIDE TOPICAL SOLUTION 45.50 %w/w MDE Replacement
183042 Q4 2022 DIMETHYL SULFOXIDE TOPICAL SOLUTION 3640mg MDE Replacement
183043 Q3 2022 DYE GREEN LB-820 ORAL TABLET 0.60 mg MDE Replacement
183044 Q4 2022 DYE GREEN LB-820 ORAL TABLET 2mg MDE Replacement
183110 Q4 2022 DL-LACTIDE AND GLYCOLIDE (75:25) COPOLYMER 20000 ACID INTRAMUSCULAR INJECTION, POWDER, FOR SUSPENSION 11mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: October 1, 2022
Database Last Updated: October 19, 2022

Back to Top